PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
18-Sep-2024 GP industrial action will undo progress made in accessing surgeries: expert London Medical Laboratory
18-Sep-2024 RSSL announces opening of new laboratory to provide advanced 3D imaging and metrology services RSSL
18-Sep-2024 Bioz Stars Revolutionizes Product Selection in Scientific Research With Objective Ratings AccessWire
18-Sep-2024 Cordlife Unveils Enhanced Processing and Storage Facility in Singapore Cordlife Group Limited
18-Sep-2024 Alfa Chemistry Enhances Household Care with a Range of Surfactants: Emulsifying, Dispersing, Antistatic, and Foaming Agents Alfa Chemistry
18-Sep-2024 Alfa Chemistry Provides Alkaloids-Related Natural Products: Saccharides, Flavonoids, Terpenoids, etc Alfa Chemistry
18-Sep-2024 Innovation Brings New Possibilities: Alfa Chemistry Newly Releases Copper Alloys, Nickel Alloys, and Titanium Alloys Alfa Chemistry
18-Sep-2024 Explore Global Trends in Hepatocellular Carcinoma Prophecy Market Insights
18-Sep-2024 Exploring Growth of Artificial Intelligence (AI) in Biotechnology Prophecy Market Insights
18-Sep-2024 Relief Therapeutics Completes Clinical Phase in RLF-OD032 Proof-of-Concept Study; Topline Results Expected in October 2024 AccessWire
18-Sep-2024 Relief Therapeutics Completes Clinical Phase in RLF-OD032 Proof-of-Concept Study; Topline Results Expected in October 2024 Relief Therapeutics Holding SA
17-Sep-2024 Dermata Therapeutics Announces Closing of $3.5 Million Private Placement Priced At-The-Market Under Nasdaq Rules AccessWire
17-Sep-2024 Epica International, Inc. Secures $18 Million Growth Capital Credit Facility From Avenue Capital Group to Drive Innovation and Expansion AccessWire
17-Sep-2024 MD Clarity Unveils Major Expansion of Its Contract Modeling Module to Empower Providers in Payer Negotiations AccessWire
17-Sep-2024 Taglich Brothers Publishes Updated Coverage Report on Cosmos Health; Maintains Price Target of $4, Nearly 300% Above Current Share Price AccessWire
17-Sep-2024 Moderna Receives Health Canada Approval For Updated COVID-19 Vaccine Targeting KP.2 Variant Of SARS-COV-2 For Ages Six Months And Older AccessWire
17-Sep-2024 CPHI Milan Report predicts BLA and Tides approvals will surpass small molecules within the next three years CPHI Milan
17-Sep-2024 AC Immune Receives Second Milestone Payment Following Progress in Phase 2b ReTain Trial of ACI-35.030 in Preclinical Alzheimer’s Disease AC Immune SA
17-Sep-2024 Improved breast cancer risk tools on the horizon as major study reaches 20-year halfway point The Institute of Cancer Research
17-Sep-2024 Arca BioLogistics Partners with Cen Global to Propel Bio-Science Logistics into The 21st Century Arca BioLogistics